Speech-Language Pathologists in Dillsburg, PA Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Clear Path Pediatric Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 413 Clemens Dr, Dillsburg, PA 17019 Phone: 717-602-2848

Elizabeth Chiodo Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 523 Ridgeview Dr, Dillsburg, PA 17019 Phone: 724-263-5727

Allison Lieberman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 413 Clemens Dr, Dillsburg, PA 17019 Phone: 717-602-2848

Erin Cover Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 413 Clemens Dr, Dillsburg, PA 17019 Phone: 717-602-2848

Mrs. Melissa Fiedler Mcaneny, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 S Alydar Blvd, Dillsburg, PA 17019 Phone: 717-432-3914

Mrs. Diane Priscilla Kern Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 27 N Baltimore St, Dillsburg, PA 17019 Phone: 717-432-4337

Kim Gray Beard, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1610 Pennsylvania Ave, Dillsburg, PA 17019 Phone: 717-432-8369

News Archive

Pediatricians should screen all children for vitamin D deficiency

As study after study shows the fundamental role vitamin D plays in disease and health, vitamin D deficiency — which often develops insidiously in childhood — should be on every parent's and pediatrician's radar, say physicians from the Johns Hopkins Children's Center.

New paper-strip test for detecting pesticides in beverage and food samples

Scientists in Canada are reporting the development of a fast, inexpensive "dipstick" test to identify small amounts of pesticides that may exist in foods and beverages. Their paper-strip test is more practical than conventional pesticide tests, producing results in minutes rather than hours by means of an easy-to-read color-change, they say.

Insurers want out of low-income segment of Medicare Part D market

UPI: "Health insurance companies have raised their premiums to price themselves out of the low-income segment of the Part D market," according to a study from the Mongan Institute for Health Policy at Massachusetts General Hospital. According to the study, "Part D reimbursements to insurers covering low-income patients are substantially lower than the actual costs incurred," which create an "'incentive for plans to avoid or shed low-income patients,'" the study's lead author said.

6-month results of NovoStent's SAMBA trial for atherosclerotic disease in SFA and popliteal arteries

NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.

People in addiction treatment programs more likely to use tobacco

People in addiction treatment programs around the world use tobacco at two to three times the rate of people who are not being treated for addiction, according to a review of research studies from 20 countries other than the United States.

Read more Medical News

› Verified 7 days ago